Literature DB >> 15588252

The Smad3 linker region contains a transcriptional activation domain.

Guannan Wang1, Jianyin Long, Isao Matsuura, Dongming He, Fang Liu.   

Abstract

Transforming growth factor-beta (TGF-beta)/Smads regulate a wide variety of biological responses through transcriptional regulation of target genes. Smad3 plays a key role in TGF-beta/Smad-mediated transcriptional responses. Here, we show that the proline-rich linker region of Smad3 contains a transcriptional activation domain. When the linker region is fused to a heterologous DNA-binding domain, it activates transcription. We show that the linker region physically interacts with p300. The adenovirus E1a protein, which binds to p300, inhibits the transcriptional activity of the linker region, and overexpression of p300 can rescue the linker-mediated transcriptional activation. In contrast, an adenovirus E1a mutant, which cannot bind to p300, does not inhibit the linker-mediated transcription. The native Smad3 protein lacking the linker region is unable to mediate TGF-beta transcriptional activation responses, although it can be phosphorylated by the TGF-beta receptor at the C-terminal tail and has a significantly increased ability to form a heteromeric complex with Smad4. We show further that the linker region and the C-terminal domain of Smad3 synergize for transcriptional activation in the presence of TGF-beta. Thus our findings uncover an important function of the Smad3 linker region in Smad-mediated transcriptional control.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15588252      PMCID: PMC1134763          DOI: 10.1042/BJ20041820

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  34 in total

1.  Interdependent SMAD and JNK signaling in transforming growth factor-beta-mediated transcription.

Authors:  M E Engel; M A McDonnell; B K Law; H L Moses
Journal:  J Biol Chem       Date:  1999-12-24       Impact factor: 5.157

Review 2.  Transcriptional control by the TGF-beta/Smad signaling system.

Authors:  J Massagué; D Wotton
Journal:  EMBO J       Date:  2000-04-17       Impact factor: 11.598

3.  Crystal structure of a transcriptionally active Smad4 fragment.

Authors:  B Qin; S S Lam; K Lin
Journal:  Structure       Date:  1999-12-15       Impact factor: 5.006

Review 4.  CBP/p300 in cell growth, transformation, and development.

Authors:  R H Goodman; S Smolik
Journal:  Genes Dev       Date:  2000-07-01       Impact factor: 11.361

5.  Inactivation of smad-transforming growth factor beta signaling by Ca(2+)-calmodulin-dependent protein kinase II.

Authors:  S J Wicks; S Lui; N Abdel-Wahab; R M Mason; A Chantry
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

6.  The Smad4 activation domain (SAD) is a proline-rich, p300-dependent transcriptional activation domain.

Authors:  M P de Caestecker; T Yahata; D Wang; W T Parks; S Huang; C S Hill; T Shioda; A B Roberts; R J Lechleider
Journal:  J Biol Chem       Date:  2000-01-21       Impact factor: 5.157

7.  The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling.

Authors:  S Itoh; J Ericsson; J Nishikawa; C H Heldin; P ten Dijke
Journal:  Nucleic Acids Res       Date:  2000-11-01       Impact factor: 16.971

8.  The MSG1 non-DNA-binding transactivator binds to the p300/CBP coactivators, enhancing their functional link to the Smad transcription factors.

Authors:  T Yahata; M P de Caestecker; R J Lechleider; S Andriole; A B Roberts; K J Isselbacher; T Shioda
Journal:  J Biol Chem       Date:  2000-03-24       Impact factor: 5.157

9.  Role of Rho/ROCK and p38 MAP kinase pathways in transforming growth factor-beta-mediated Smad-dependent growth inhibition of human breast carcinoma cells in vivo.

Authors:  Anil K Kamaraju; Anita B Roberts
Journal:  J Biol Chem       Date:  2004-11-01       Impact factor: 5.157

10.  SMIF, a Smad4-interacting protein that functions as a co-activator in TGFbeta signalling.

Authors:  Ren-Yuan Bai; Christina Koester; Tao Ouyang; Stephan A Hahn; Matthias Hammerschmidt; Christian Peschel; Justus Duyster
Journal:  Nat Cell Biol       Date:  2002-03       Impact factor: 28.824

View more
  18 in total

1.  Smads orchestrate specific histone modifications and chromatin remodeling to activate transcription.

Authors:  Sarah Ross; Edwin Cheung; Thodoris G Petrakis; Michael Howell; W Lee Kraus; Caroline S Hill
Journal:  EMBO J       Date:  2006-09-21       Impact factor: 11.598

2.  MAPK inhibitors differently modulate TGF-β/Smad signaling in HepG2 cells.

Authors:  A Boye; H Kan; C Wu; Y Jiang; X Yang; S He; Y Yang
Journal:  Tumour Biol       Date:  2015-01-07

Review 3.  Smad3 phospho-isoform signaling in hepatitis C virus-related chronic liver diseases.

Authors:  Takashi Yamaguchi; Katsunori Yoshida; Miki Murata; Koichi Matsuzaki
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

4.  Cyclin-dependent kinase 4-mediated phosphorylation inhibits Smad3 activity in cyclin D-overexpressing breast cancer cells.

Authors:  Stanislav Zelivianski; Anne Cooley; Ron Kall; Jacqueline S Jeruss
Journal:  Mol Cancer Res       Date:  2010-08-24       Impact factor: 5.852

5.  c-Jun N-terminal kinase 1 promotes transforming growth factor-β1-induced epithelial-to-mesenchymal transition via control of linker phosphorylation and transcriptional activity of Smad3.

Authors:  Jos L J van der Velden; John F Alcorn; Amy S Guala; Elsbeth C H L Badura; Yvonne M W Janssen-Heininger
Journal:  Am J Respir Cell Mol Biol       Date:  2010-06-25       Impact factor: 6.914

6.  Regulation of chondroitin-4-sulfotransferase (CHST11) expression by opposing effects of arylsulfatase B on BMP4 and Wnt9A.

Authors:  Sumit Bhattacharyya; Leo Feferman; Joanne K Tobacman
Journal:  Biochim Biophys Acta       Date:  2014-12-12

7.  Transforming growth factor-{beta}-inducible phosphorylation of Smad3.

Authors:  Guannan Wang; Isao Matsuura; Dongming He; Fang Liu
Journal:  J Biol Chem       Date:  2009-02-13       Impact factor: 5.157

8.  Rewiring of the apoptotic TGF-β-SMAD/NFκB pathway through an oncogenic function of p27 in human papillary thyroid cancer.

Authors:  A R Garcia-Rendueles; J S Rodrigues; M E R Garcia-Rendueles; M Suarez-Fariña; S Perez-Romero; F Barreiro; I Bernabeu; J Rodriguez-Garcia; L Fugazzola; T Sakai; F Liu; J Cameselle-Teijeiro; S B Bravo; C V Alvarez
Journal:  Oncogene       Date:  2016-07-25       Impact factor: 9.867

9.  A negative feedback control of transforming growth factor-beta signaling by glycogen synthase kinase 3-mediated Smad3 linker phosphorylation at Ser-204.

Authors:  Caroline Millet; Motozo Yamashita; Mary Heller; Li-Rong Yu; Timothy D Veenstra; Ying E Zhang
Journal:  J Biol Chem       Date:  2009-05-19       Impact factor: 5.157

10.  Serine-204 in the linker region of Smad3 mediates the collagen-I response to TGF-β in a cell phenotype-specific manner.

Authors:  J A Browne; X Liu; H W Schnaper; T Hayashida
Journal:  Exp Cell Res       Date:  2013-09-27       Impact factor: 3.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.